OC07.02: Multicentre screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison to NICE guidelines and ACOG recommendations.

MLA

O’Gorman, N., et al. “OC07.02: Multicentre Screening for Pre-Eclampsia by Maternal Factors and Biomarkers at 11-13 Weeks’ Gestation: Comparison to NICE Guidelines and ACOG Recommendations.” Ultrasound in Obstetrics & Gynecology, vol. 50, Sept. 2017, p. 13. EBSCOhost, https://doi.org/10.1002/uog.17601.

APA

O’Gorman, N., Wright, D., Poon, L., Rolnik, D. L., Syngelaki, A., De Alvarado, M., Carbone, F., Dutemeyer, V., Fiolna, M., Frick, A., Karagiotis, N., Mastrodima, S., de Paco Matallana, C., Papaioannou, G., Pazos, A., Plasencia, W., & Nicolaides, K. H. (2017). OC07.02: Multicentre screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation: comparison to NICE guidelines and ACOG recommendations. Ultrasound in Obstetrics & Gynecology, 50, 13. https://doi.org/10.1002/uog.17601

Chicago

O’Gorman, N., D. Wright, L. Poon, D.L. Rolnik, A. Syngelaki, M. De Alvarado, F. Carbone, et al. 2017. “OC07.02: Multicentre Screening for Pre-Eclampsia by Maternal Factors and Biomarkers at 11-13 Weeks’ Gestation: Comparison to NICE Guidelines and ACOG Recommendations.” Ultrasound in Obstetrics & Gynecology 50 (September): 13. doi:10.1002/uog.17601.